ENDRA Life Sciences Announces 3 New Patents
Portfolio Pulse from Benzinga Newsdesk
ENDRA Life Sciences has been granted three new patents enhancing its TAEUS system, aimed at improving thermoacoustic measurements and monitoring tissue temperature during medical procedures. The patents include a novel sleeve-type probe, a thermal ablation system with integrated temperature measurement, and a method for monitoring tissue temperature, issued in the U.S., China, and Europe respectively.
February 14, 2024 | 1:33 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The issuance of three new patents strengthens ENDRA Life Sciences' TAEUS system, potentially enhancing its market position and product appeal in the medical technology sector.
The acquisition of these patents directly impacts ENDRA Life Sciences by potentially increasing the competitiveness and technological edge of its TAEUS system in the medical technology market. This could lead to increased interest from the medical community and investors, positively affecting NDRA's stock in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100